← Back to Search

Behavioural Intervention

Fitness Tracker for Prostate Cancer Survivors

N/A

Recruiting

Led By Emma Fortune Ngufor, PhD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Are 18 years of age or older

Are not currently undergoing adjunct cancer therapy (e.g. chemotherapy, radiation) during the 12-weeks of study participation, except oral tyrosine kinase inhibitor or hormonal therapies

Must not have

Are on prolonged bed rest (i.e., more than half of the waking day in bed) by self-report

Are unable to walk for at least one block without a walking aide by self-report

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 8 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if using the InBody Band 3 fitness tracker can help improve physical activity, body composition, and quality of life in Black prostate cancer survivors. Prostate cancer is common in

Who is the study for?

This trial is for Black prostate cancer survivors to see if the InBody Band 3 fitness tracker can help improve their physical activity, body composition, and quality of life. Participants should be willing to use the device and share data on their activity levels, stress, sleep patterns, and body composition.

What is being tested?

The study is testing whether using the InBody Band 3 fitness tracker encourages better health habits in Black prostate cancer survivors. It involves discussions with researchers, answering questionnaires, and regular usage of this medical device to monitor various health metrics.

What are the potential side effects?

Since this trial involves a non-invasive fitness tracker rather than medication or invasive procedures, there are no direct side effects from interventions. However, participants may experience discomfort or skin irritation from wearing the device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am not on chemotherapy or radiation but may be on hormonal therapy or taking a tyrosine kinase inhibitor.

Select...

I have been diagnosed with prostate cancer at any stage.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I spend most of my day in bed.

Select...

I cannot walk a block without help.

Select...

I cannot walk a block due to a leg injury.

Select...

I use a wheelchair for getting around.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Adherence rate

Change in acceptability scale score

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive care (InBody Band 3 fitness tracker)Experimental Treatment3 Interventions

Patients wear the InBody Band 3 fitness tracker continuously and participate in check-in/goal-setting discussions over 20-30 minutes weekly for 6 weeks.

0 / 7Eligibility criteria met